Keywords: genentech, licenses, immunogen, tap, tech, says, fellow

Genentech licenses more ImmunoGen TAP tech

Article | 15 December 2008

Print This

ImmunoGen says that fellow USA-based Genentech has licensed the exclusive right to use its Tumor-Activated Prodrug (TAP) technology with the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in